Each week seems to bring another incredible story about what’s becoming possible in cancer medicine: A personalized vaccine succeeds in a late-stage trial for melanoma patients. A new drug nearly doubles survival for people with pancreatic cancer.
As powerful emerging treatment approaches and technologies, including AI, provide new reasons for optimism, we’re determined to make sure chordoma patients benefit from breakthroughs like these, too.
Nearly two decades of compounding progress driven by this community have cleared many of the roadblocks that once made that impossible, and paved the way for much more significant advances in the coming years.
To that end, we’re excited to share our new 2026-2030 Strategic Plan. It lays out how we’ll capitalize on remarkable strides in cancer research and drug development to meaningfully improve chordoma treatment options while helping more patients get the best possible care and support along the way. And because achieving these ambitions will require roughly doubling the investment in our mission, it also describes how we’ll mobilize more people and resources behind our shared drive to improve the outlook for everyone affected by this disease.
We now have an extraordinary opportunity to turn the awe-inspiring progress reshaping what’s possible in science and medicine into a markedly better future for people facing chordoma. On behalf of our staff and Board of Directors, we’re deeply grateful for everything this community has done over the past 20 years to bring us to this moment, and to have you standing with us as we seize it.
Bringing our vision for 2030 to life will take all of us, and there will be many ways to play a part. Our team is here to help you find meaningful ways to participate, and we welcome you to get in touch about how you’d like to be involved.